| ACET Stock | | | USD 0.91 0.06 6.19% |
This module uses fundamental data of Adicet Bio to approximate its Piotroski F score. Adicet Bio F Score is determined by combining nine binary scores representing 3 distinct fundamental categories of Adicet Bio. These three categories are profitability, efficiency, and funding. Some research analysts and sophisticated value traders use Piotroski F Score to find opportunities outside of the conventional market and financial statement analysis.They believe that some of the new information about Adicet Bio financial position does not get reflected in the current market share price suggesting a possibility of arbitrage. Check out
Adicet Bio Altman Z Score,
Adicet Bio Correlation,
Adicet Bio Valuation, as well as analyze
Adicet Bio Alpha and Beta and
Adicet Bio Hype Analysis.
For more information on how to buy Adicet Stock please use our
How to Invest in Adicet Bio guide.
Net Debt To EBITDA is likely to gain to 1.07 in 2024, whereas
Short and Long Term Debt Total is likely to drop slightly above 19.9
M in 2024. At this time, Adicet Bio's
Net Debt To EBITDA is comparatively stable compared to the past year.
Receivables Turnover is likely to gain to 54.29 in 2024, whereas
Days Sales Outstanding is likely to drop 5.43 in 2024.
At this time, it appears that Adicet Bio's Piotroski F Score is Unavailable. Although some professional money managers and academia have recently criticized
Piotroski F-Score model, we still consider it an effective method of
predicting the state of the financial strength of any organization that is not predisposed to accounting gimmicks and manipulations. Using this score on the criteria to originate an efficient long-term portfolio can help investors filter out the purely speculative stocks or equities playing fundamental games by manipulating their earnings..
5.0
Piotroski F Score - Unavailable
| Change in Return on Assets | |
| Cash Flow Return on Assets | |
| Current Quality of Earnings (accrual) | |
| Long Term Debt Over Assets Change | |
| Change In Outstending Shares | |
Adicet Bio Piotroski F Score Drivers
The critical factor to consider when applying the Piotroski F Score to Adicet Bio is to make sure Adicet is not a subject of accounting manipulations and runs a healthy internal audit department. So, if Adicet Bio's auditors report directly to the board (not management), the managers will be reluctant to manipulate simply due to the fear of punishment. On the other hand, the auditors will be free to investigate the ledgers properly because they know that the board has their back. Below are the main accounts that are used in the Piotroski F Score model. By analyzing the historical trends of the mains drivers, investors can determine if Adicet Bio's financial numbers are properly reported.
Adicet Bio F Score Driver Matrix
One of the toughest challenges investors face today is learning how to quickly synthesize historical
financial statements and information provided by the company, SEC reporting, and various external parties in order to project the various growth rates. Understanding the correlation between Adicet Bio's different financial indicators related to revenue, expenses, operating profit, and net earnings helps investors identify and prioritize their investing strategies towards Adicet Bio in a much-optimized way.
Click cells to compare fundamentals
About Adicet Bio Piotroski F Score
F-Score is one of many stock grading techniques developed by Joseph Piotroski, a professor of accounting at the Stanford University Graduate School of Business. It was published in 2002 under the paper titled
Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers. Piotroski F Score is based on binary analysis strategy in which stocks are given one point for passing 9 very simple fundamental tests, and zero point otherwise. According to Mr. Piotroski's analysis, his F-Score binary model can help to predict the performance of low price-to-book stocks.
Adicet Bio Current Valuation Drivers
We derive many important indicators used in calculating different scores of Adicet Bio from analyzing Adicet Bio's financial statements. These drivers represent accounts that assess Adicet Bio's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Adicet Bio's important valuation drivers and their relationship over time.
| | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) |
| Market Cap | | 193.6M | 102.8M | 541.4M | 367.3M | 81.4M | 77.3M |
| Enterprise Value | | 297.0M | 40.2M | 284.8M | 130.6M | (57.4M) | (54.6M) |
About Adicet Bio Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Adicet Bio's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Adicet Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at
the intrinsic value of Adicet Bio based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing
financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our
fundamental analysis page.
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Additional Tools for Adicet Stock Analysis
When running Adicet Bio's price analysis, check to
measure Adicet Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Adicet Bio is operating at the current time. Most of Adicet Bio's value examination focuses on studying past and present price action to
predict the probability of Adicet Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Adicet Bio's price. Additionally, you may evaluate how the addition of Adicet Bio to your portfolios can decrease your overall portfolio volatility.